Exim Routes Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Exim Routes Ltd is ₹ 84.3 as of 23 Oct 15:30 . The P/E Ratio of Exim Routes Ltd changed from 23.7 on March 2026 to 23.7 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Exim Routes Ltd changed from ₹ 243.12 crore on March 2026 to ₹ 243.12 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of Exim Routes Ltd is ₹ 2.95 crore as of Sep '24 .The Revenue of Genomic Valley Biotech Ltd is ₹ 0 crore as of Sep '24 . The EBITDA of Exim Routes Ltd is ₹ 1.79 crore as of Sep '24 .The EBITDA of Genomic Valley Biotech Ltd is ₹ 0 crore as of Sep '24 . The Net Profit of Exim Routes Ltd is ₹ 1.27 crore as of Sep '24 .The Net Profit of Genomic Valley Biotech Ltd is ₹ 0 crore as of Sep '24 . The Dividend Payout of Exim Routes Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Exim Routes Ltd

Exim Routes Limited was originally incorporated as a private Limited Company with the name of 'Exim Routes Private Limited' under the Companies Act, 2013 dated April 23, 2019, issued by Registrar of Companies, NCT of Delhi and Haryana.
Further, the status of the Company was converted into a Public Limited and the name was changed to 'Exim Routes Limited' vide fresh certificate of incorporation dated October 24, 2024 issued by the Central Processing Centre. Company operates as a global platform enabling the exchange of recyclable paper materials, offering end-to-end services to Indian Paper Mills-from sourcing to logistics.
Central to this, Company has developed the Exim Routes Intelligence System (ERIS), an AI powered B2B digital platform, designed to perform four primary functions: Firstly, in Supply Chain Operations and Offer Management, the ERIS platform consolidates global inventory data from all Exim Route Limited suppliers, demand offers from mills, matching and price discovery, and connects supply and demand by acting as an intermediary, enabling bidding and closing of trades.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of Exim Routes Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, Exim Routes Ltd or Genomic Valley Biotech Ltd?

Market cap of Exim Routes Ltd is 158 Cr while Market cap of Genomic Valley Biotech Ltd is 11 Cr

What are the key factors driving the stock performance of Exim Routes Ltd and Genomic Valley Biotech Ltd?

The stock performance of Exim Routes Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Exim Routes Ltd and Genomic Valley Biotech Ltd?

As of October 25, 2026, the Exim Routes Ltd stock price is INR ₹84.3. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹37.71.

How do dividend payouts of Exim Routes Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of Exim Routes Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.